⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PROK News
ProKidney Corp. Class A Ordinary Shares
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
prnewswire.com
MLYS
PROK
IRON
REGN
AMGN
MAZE
LLY
JNJ
LXRX
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
PROK
Beyond Insulin Pumps: Cell Therapies Unlock a $403B Cure Economy
prnewswire.com
PROK
MESO
LCTX
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
globenewswire.com
PROK
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
globenewswire.com
PROK
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
globenewswire.com
PROK